BlackRock’s ArriVent BioPharma AVBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $40M | Sell |
1,838,376
-301,412
| -14% | -$6.56M | ﹤0.01% | 2551 |
|
|
2025
Q1 | $39.6M | Buy |
2,139,788
+4,696
| +0.2% | +$86.8K | ﹤0.01% | 2475 |
|
|
2024
Q4 | $56.9M | Buy |
2,135,092
+203,673
| +11% | +$5.43M | ﹤0.01% | 2347 |
|
|
2024
Q3 | $45.4M | Buy |
1,931,419
+1,268,154
| +191% | +$29.8M | ﹤0.01% | 2489 |
|
|
2024
Q2 | $12.3M | Buy |
663,265
+8,461
| +1% | +$157K | ﹤0.01% | 3207 |
|
|
2024
Q1 | $11.7M | Buy |
+654,804
| New | +$11.7M | ﹤0.01% | 3215 |
|